ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,441,859 | -36.2% | 454,845 | 0.0% | 0.04% | -27.1% |
Q2 2023 | $2,260,580 | +390.7% | 454,845 | +387.8% | 0.05% | +140.0% |
Q1 2023 | $460,645 | -21.5% | 93,248 | 0.0% | 0.02% | -28.6% |
Q4 2022 | $586,530 | -41.8% | 93,248 | 0.0% | 0.03% | -53.3% |
Q3 2022 | $1,007,000 | -5.3% | 93,248 | 0.0% | 0.06% | -16.7% |
Q2 2022 | $1,063,000 | +25.2% | 93,248 | 0.0% | 0.07% | +71.4% |
Q1 2022 | $849,000 | -39.0% | 93,248 | 0.0% | 0.04% | -34.4% |
Q4 2021 | $1,391,000 | -41.9% | 93,248 | 0.0% | 0.06% | -41.8% |
Q3 2021 | $2,396,000 | -1.5% | 93,248 | 0.0% | 0.11% | +1.9% |
Q2 2021 | $2,432,000 | -34.9% | 93,248 | -11.8% | 0.11% | -34.1% |
Q1 2021 | $3,733,000 | +13.1% | 105,754 | -19.1% | 0.16% | -13.2% |
Q4 2020 | $3,301,000 | -36.1% | 130,766 | -4.6% | 0.19% | -40.6% |
Q3 2020 | $5,167,000 | -18.8% | 137,019 | -7.8% | 0.32% | +1.3% |
Q2 2020 | $6,366,000 | +96.1% | 148,664 | -11.0% | 0.31% | +41.4% |
Q1 2020 | $3,246,000 | -32.0% | 166,990 | -9.1% | 0.22% | -38.5% |
Q4 2019 | $4,774,000 | – | 183,750 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |